A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...

Final overall survival results show amivantamab plus lazertinib beat out osimertinib for first-line treatment of advanced ...

Due to innovations in science, animal tests are being replaced in areas such as toxicity testing, neuroscience and drug development. But much more needs to be done. Once new non-animal methods have ...